IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycolysis

Chengcheng Song(Northeast Normal University), Quan Hong(Chinese PLA General Hospital), Xiaodong Geng(Chinese PLA General Hospital), Zhangning Fu(Chinese PLA General Hospital), Kun Chi(Chinese PLA General Hospital), Shuqiang Wang(Shanghai Jiao Tong University), Chao Liu(Harbin Medical University), Xiangmei Chen(State Administration of Traditional Chinese Medicine of the People's Republic of China), Di Wu(Shenzhen Second People's Hospital), Guangyan Cai(Chinese PLA General Hospital)
Cell Death and Disease
April 13, 2022
10.1038/s41419-022-04803-y
Cited by 111

Related Papers

Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
|Nature|2021|531
Skin lesion segmentation via generative adversarial networks with dual discriminators
|Medical Image Analysis|2020|278
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273
LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β–Induced Angiogenesis
|Journal of the American Society of Nephrology|2019|149
Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression
|Science Advances|2023|130